Enhanced acyclovir delivery using w/o type microemulsion: preclinical assessment of antiviral activity using murine model of zosteriform cutaneous HSV-1 infection

References

• Ryan KJ, Ray CGSMM. Sherris medical microbiology. 4th ed. New York (NY): McGraw Hill; 2004.
   Google Scholar
• Kleymann G. Helicase primase: targeting the Achilles heel of herpes simplex viruses. Antivir Chem Chemother. 2004;15:135–140.
   PubMedGoogle Scholar
• Jain S, Mistry MA, Swarnakar NK. Enhanced dermal delivery of acyclovir using solid lipid nanoparticles. Drug Deliv Transl Res. 2011;1:395–406.
   PubMed Web of Science ®Google Scholar
• Bolger GT, Allen T, Garneau M, et al. Cutaneously applied acyclovir acts systemically in the treatment of herpetic infection in the hairless mouse. Antiviral Res. 1997;35:157–165.
   PubMed Web of Science ®Google Scholar
• Bryson YJ, Dillon M, Lovett M, et al. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med. 1983;308:916–921.
   PubMed Web of Science ®Google Scholar
• Fiddian AP, Yeo JM, Clark AE. Treatment of herpes labialis. J Infect. 1983;6:41–47.
   PubMed Web of Science ®Google Scholar
• Freeman DJ, Sheth NV, Spruance SL. Failure of topical acyclovir in ointment to penetrate human skin. Antimicrob Agents Chemother. 1986;29:730–732.
   PubMed Web of Science ®Google Scholar
• Parry GE, Dunn P, Shah VP, et al. Acyclovir bioavailability in human skin. J Invest Dermatol. 1992;98:856–863.
   PubMed Web of Science ®Google Scholar
• Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2000;45:89–121.
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2004;56:603–618.
   PubMed Web of Science ®Google Scholar
• Hua N, Liu W, Guo RC. Development and evaluation of terpene penetration enhancers. Zhongguo Zhong Yao Za Zhi. 2008;33:2875–2882.
   PubMedGoogle Scholar
• Vaddi HK, Ho PC, Chan SY. Terpenes in propylene glycol as skin-penetration enhancers: permeation and partition of haloperidol, Fourier transform infrared spectroscopy, and differential scanning calorimetry. J Pharm Sci. 2002;91:1639–1651.
   PubMed Web of Science ®Google Scholar
• Patel T, Ishiuji Y, Yosipovitch G. Menthol: a refreshing look at this ancient compound. J Am Acad Dermatol. 2007;57:873–878.
   PubMed Web of Science ®Google Scholar
• Jain AK, Thomas NS, Panchagnula R. Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes. J Control Release. 2002;79:93–101.
   PubMed Web of Science ®Google Scholar
• Godwin DA, Michniak BB. Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. Drug Dev Ind Pharm. 1999;25:905–915.
   PubMed Web of Science ®Google Scholar
• Tas C, Ozkan Y, Okyar A, et al. In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers. Drug Deliv. 2007;14:453–459.
   PubMed Web of Science ®Google Scholar
• Chang JS, Tsai YH, Wu PC, et al. The effect of mixed-solvent and terpenes on percutaneous absorption of meloxicam gel. Drug Dev Ind Pharm. 2007;33:984–989.
   PubMed Web of Science ®Google Scholar
• Rizwan M, Aqil M, Ahad A, et al. Transdermal delivery of valsartan: I. Effect of various terpenes. Drug Dev Ind Pharm. 2008;34:618–626.
   PubMed Web of Science ®Google Scholar
• Narishetty ST, Panchagnula R. Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. J Control Release. 2004;95:367–379.
   PubMed Web of Science ®Google Scholar
• Avdeef A. Solubility of sparingly-soluble ionizable drugs. Adv Drug Deliv Rev. 2007;59:568–590.
   PubMed Web of Science ®Google Scholar
• Sharma G, Dhankar G, Thakur K, et al. Benzyl benzoate-loaded microemulsion for topical applications: enhanced dermatokinetic profile and better delivery promises. AAPS PharmSciTech. 2016;17:1221–1231.
   PubMed Web of Science ®Google Scholar
• Shojaei AH, Berner B, Xiaoling L. Transbuccal delivery of acyclovir: I. In vitro determination of routes of buccal transport. Pharm Res. 1998;15:1182–1188.
   PubMed Web of Science ®Google Scholar
• Chhibber T, Wadhwa S, Chadha P, et al. Phospholipid structured microemulsion as effective carrier system with potential in methicillin sensitive Staphylococcus aureus (MSSA) involved burn wound infection. J Drug Target. 2015;23:943–952.
   PubMed Web of Science ®Google Scholar
• Schmidts T, Nocker P, Lavi G, et al. Development of an alternative, time and cost saving method of creating pseudoternary diagrams using the example of a microemulsion. Colloid Surf A: Physicochem Eng Aspects. 2009;340:187–192.
   Web of Science ®Google Scholar
• Negi P, Singh B, Sharma G, et al. Phospholipid microemulsion-based hydrogel for enhanced topical delivery of lidocaine and prilocaine: QbD-based development and evaluation. Drug Deliv. 2016;23:951–967.
   PubMed Web of Science ®Google Scholar
• Roland I, Piel G, Delattre L, et al. Systematic characterization of oil-in-water emulsions for formulation design. Int J Pharm. 2003;263:85–94.
   PubMed Web of Science ®Google Scholar
• Zhu W, Guo C, Yu A, et al. Microemulsion-based hydrogel formulation of penciclovir for topical delivery. Int J Pharm. 2009;378:152–158.
   PubMed Web of Science ®Google Scholar
• Bolzinger MA, Briancon S, Pelletier J, et al. Percutaneous release of caffeine from microemulsion, emulsion and gel dosage forms. Eur J Pharm Biopharm. 2008;68:446–451.
   PubMed Web of Science ®Google Scholar
• Jain S, Jain P, Umamaheshwari RB, et al. Transfersomes-a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm. 2003;29:1013–1026.
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu JP, Zhang X, et al. Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int J Pharm. 2006;327:58–64. Epub 2006 Jul 21.
   PubMed Web of Science ®Google Scholar
• Piret J, Desormeaux A, Gourde P, et al. Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection. Antimicrob Agents Chemother. 2000;44:30–38.
   PubMed Web of Science ®Google Scholar
• Koch C, Reichling J, Schneele J, et al. Inhibitory effect of essential oils against herpes simplex virus type 2. Phytomedicine. 2008;15:71–78.
   PubMed Web of Science ®Google Scholar
• Sakuma S, Yamamoto M, Kumano Y, et al. An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice. Arch Virol. 1988;101:169–182.
   PubMed Web of Science ®Google Scholar
• Alam P, Ansari MJ, Anwer MK, et al. Wound healing effects of nanoemulsion containing clove essential oil. Artif Cells Nanomed Biotechnol. 2017;45:591–597.
   PubMed Web of Science ®Google Scholar
• Laxmi M, Bhardwaj A, Mehta S, et al. Development and characterization of nanoemulsion as carrier for the enhancement of bioavailability of artemether. Artif Cells Nanomed Biotechnol. 2015;43:334–344.
   PubMed Web of Science ®Google Scholar
• Davis SS, Hadgraft J, Al-Khamis K. Percutaneous absorption of methyl salicylate from propylene glycol vehicles. J Pharm Pharmacol. 1981;33:97–102.
   Google Scholar
• Barrett CW, Hadgraft JW, Sarkany I. The influence of vehicles on skin penetration. J Pharm Pharmacol. 1964;16:SUPPL:104–SUP7T.
   Web of Science ®Google Scholar
• Wang F, Kief E. Viral diseases. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, editors. Harrison’s principles of internal medicine. Singapore: McGraw-Hill; 1998. p. 1076–1085.
   Google Scholar